Genomics|Update|Current: Reproductive Health

Genomics|Update|Current

Reproductive Health

Changes in prenatal testing trends after introduction of noninvasive prenatal testing

Larion S, et al. Obstet Gynecol 2014 May;123 Suppl 1:62S-3S

Effect of commercial cell-free fetal DNA tests for aneuploidy screening on rates of invasive testing

Louis-Jacques A, et al. Obstet Gynecol 2014 May;123 Suppl 1:67S

Noninvasive prenatal testing compared with invasive diagnostic testing in the setting of an abnormal state aneuploidy screen

Rad S, et al. Obstet Gynecol 2014 May;123 Suppl 1:100S

Noninvasive prenatal testing decreased diagnostic testing but not first-trimester screening

Larion S, et al. Obstet Gynecol 2014 May;123 Suppl 1:88S

Preferences for results from genomic microarrays: comparing parents and health care providers

Turbitt E, et al. Clin Genet 2014 Apr

Two different microarray technologies for preimplantation genetic diagnosis and screening, due to reciprocal translocation imbalances, demonstrate equivalent euploidy and clinical pregnancy rates

Tobler KJ, et al. J Assist Reprod Genet 2014 Apr

Use of commercial tests for aneuploidy screening using cell-free fetal DNA in clinical practice

Louis-Jacques A, et al. Obstet Gynecol 2014 May;123 Suppl 1:154S